Freezing of gait unresponsive to dopaminergic stimulation in patients with severe Parkinsonism;Bloqueos de la marcha sin respuesta al estímulo dopaminérgico con apomorfina en pacientes parkinsonianos graves

Neurologia

Volumn 25, Issue 1, 2010, Pages 27-31

  Vaamonde Gamo, J ^a   Cabello, J P ^a   Gallardo Alcaniz M J ^a   Flores Barragan, J M ^a   Carrasco Garcia de Leon S ^a   Ibanez Alonso R E ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

Author keywords

Apomorphine; Freezing; Parkinson's disease

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; DOMPERIDONE; LEVODOPA; PRAMIPEXOLE; RASAGILINE; ROPINIROLE; ANTIPARKINSON AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGED; ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; DISEASE SEVERITY; DYSKINESIA; FREEZING OF GAIT; GAIT DISORDER; HUMAN; MOTOR DYSFUNCTION; PARAMETER; PARKINSON DISEASE; PARKINSONISM; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE; COMPLICATION; DYSKINESIAS; GAIT; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANTIPARKINSON AGENTS; APOMORPHINE; DOPAMINE; DOPAMINE AGENTS; DYSKINESIAS; GAIT; HUMANS; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 77954852745     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/S0213-4853(10)70019-0     Document Type: Article

References (40)

1. Giladi N., Hausdorff J.M., Balash Y. Episodic and continuous gait disturbances in Parkinson's disease. The scientific basis for the treatment of Parkinson's disease 2004, Parthenon, Lancaster. N. Galvez-Jiménez (Ed.).
2. Nutt J.G., Marsden D., Thompson P.D. Human walking and higher-level gait disorders particularly in the elderly. Neurology 1993, 43:268-279.
3. Marsden C.D., Thompson P.D. Toward a nosology of gait disorders: descriptive classification. Gait disorders of aging. Falls and therapeutic strategies 1997, 135-146. Lippincott-Raven, Philadelphia. J. Masdeu, L. Surdarsky, L. Walfson (Eds.).
4. Wichmann T., DeLong M.R. Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv Neurol 2003, 91:9-18.
5. Parkinson J. An essay on the shaking palsy 1817, Neely and Jones, London: Sherwood.
6. Koller W.C. A essay on the shaking palsy: James Parkinson's description compared to current concepts. Neurology 1983, 33(Suppl):150.
7. Ambani L.M., Van Woert M.H. Start hesitation -a side effect of long term levodopatherapy. N Engl J Med 1973, 288:1113-1115.
8. Schaafsma J.D., Balash Y., Gurevich T., Bartels A.L., Hausdorff J.M., Giladi N. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur J Neurol 2003, 10:391-398.
9. Giladi N., Shabthai H., Rozenberg E., Shabthai E. Gait festination in Parkinson's disease. Parkinsonism Relat Disord 2001, 7:135-138.
10. Bloem B., Van Vuggt J., Beckley D. Postural instability and falls in Parkinson's disease. Adv Neurol 2001, 87:209-223.
11. Selby G. The long term prognosis of Parkinson's disease. Clin Exp Neurol 1984, 20:1-25.
12. Giladi N., Kao R., Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov Disord 1997, 12:302-305.
13. Lamberti P., Armenise S., Castaldo, Vde Mari M., Iliceto G., Tronci P., et al. Freezing gait in Parkinson's disease. Eur Neurol 1997, 38:297-301.
14. Okuma Y., Yanagisawa N. The clinical spectrum of freezing of gait in Parkinson's disease. Mov Disord 2008, 23(Suppl):426-430.
15. Bartels A.L., Balash Y., Gurevich T., Schaafsma J.D., Hausdorff J.M., Giladi N. Relationships between freezing of gait (FOG) and others features of Parkinson's disease. FOG is not corraleted with bradykinesia. J Clin Neurosci 2003, 10:584-588.
16. Giladi N., Treves T.A., Simon S.E., Shabtai H., Orlov Y. Freezing of gait in patients with aadvanced Parkinson's disease. J Neural Trasm 2001, 108:53-61.
17. Barbeau A. Six years of high-level levodopa therapy in severely akinetic parkinsonian patients. Arch Neurol 1976, 33:333-338.
18. Factor S., Jennings D.L., Molho E.S., Marek K.L. The natural history of the syndrome of primary progressive freezing gait. Arch Neurol 2002, 59:1778-1783.
19. Imai H. Syndrome of pure akinesia or freezing phenomenon without rigidity and tremor and with no effect jof L-Dopa therapy. Adv Neurol Res (Tokyo) 1980, 24:838-848.
20. Plotnik M., Hausdorff J.M. The role of gait rhythmicity and bilateral coordination of stepping in the pathophysiology of freezing of gait in Parkinson's disease. Mov Disord 2008, 23(Suppl 2):S444-S450.
21. Giladi N., Haussdorff J.M. The role of mental function in the pathogenesis of freezing of gait in Parkinson's disease. J Neurol Sci 2006, 248:173-176.
22. Matsui H., Udaka F., Miyoshi T., Hara N., Tamaura A. Three-dimensional stereotactic surgace projection study of freezing of gait and perfusion image in Parkinson's disease. Mov Disord 2005, 20:1272-1277.
23. Huang C., Mattis P., Tang C., Perrine K., Carbon M., Eidelberg D. Metabolic brain networks associated with cognitive function in Parkinson's disease. Neuroimage 2007, 34:714-723.
24. Pahapill P.A., Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 2000, 123:1767-1783.
25. Kuo S.H., Jankovic K.C. Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov Disord 2008, 23:616-619.
26. Nieuwboer A., Domn R., De Weerdt W., Desloovere K., Janssens L., Stijin V. Electromyographic profiles of gait prior to onset of freezing episodes in patients with Parkinson's disease. Brain 2004, 127:1650-1660.
27. Stern G.M., Lander C.M., Lees A.J. Akinetic freezing and trick movements in Parkinson's disease. J Neural Transm Suppl 1980, 16(Suppl):137-141.
28. Hallet M. The intrinsic and extrinsic aspects of freezing of gait. Mov Disord 2008, 22(Suppl):S439-S443.
29. Sacco K., Cauda F., Cerliani L., Mate D., Duca S., Germiniani G.C. Motor imagery of walking following training in locomotor attention. The effect of " the tango lesson" Neuroimage 2006, 32:1441-1449.
30. Camicioli R., Oken B.S., Sexton O., Kaye J.A., Nutt J.G. Verbal fluency task affects gait in Parkinson's disease with motor freezing. J Geriatr Psychiatry Neurol 1998, 11:181-185.
31. Rascol O., Brooks D.J., Korczyn A.D., DeDeyn P.P., Clarke C.E., Lang A.E. A five year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med 2003, 342:1484-1491. The 056 study group.
32. Pramipexole vs levodopa as initial treatment for Parkinson's disese. A 4-year randomized controlled trial. Arch Neurol 2004, 61:1044-1053. The Parkinson Study Group.
33. Giladi N., McDemott M.P., Fahn S., Przedborski J. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 2001, 56:1712-1721.
34. Elmer L.W., Bertoni J.M. The incrising role of monoamine oxidase type B inhibitors in Parkinson's disease therapy. Expert Opin Pharmacother 2008, 9:2759-2772.
35. Auriel E., Hausdorff J.M., Herman T., Simon E.S., Giladi N. Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease. A pilot study. Clin Neuropharmacol 2006, 29:15-17.
36. Kitagawa M., Houzen H., Tashiro K. Effects of caffeine on the freezing of gait in Parkinson's disease. Mov Disord 2007, 22:710-712.
37. Wieler M., Camicioli R., Jones C.A., Martin W.R. Botulinum toxin injections do not improve frezzing of gait in Parkinson's disease. Neurology 2005, 65:626-628.
38. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003, 349:1925-1934.
39. Pahapill P., Lozano A.M. The pedunculopontine nucleus and Parkinson's disease. Brain 2000, 123:1767-1783.
40. Nieuwboer A., Kwakkel G., Rochester L., Jones D., Van Wegen E., Willems A.M., et al. Cueing training in the home improves gait-related mobility in Parkinson's disease: the RESCUE trial. J Neurol Neurosurg Psychiatry 2007, 78:134-140.